Arch Biopartners Announces Positive Results of Dose Escalation Human Trial for LSALT Peptide Industrial Metals Investing
Buffalo Coal Corp. Announces Results of Special Meeting of Shareholders for Going Private Transaction Industrial Metals Investing
Arch Biopartners Receives Funding for Development of LSALT Peptide Drug Program Industrial Metals Investing
Buffalo Coal Corp. Announces Special Meeting of Shareholders for Going Private Transaction Industrial Metals Investing
Arch Scientist Awarded CIHR Grant to Study the Role of Dipeptidase-1 in Chronic Kidney Disease Industrial Metals Investing
